Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 3/20 | 0.65 |
| ▸ | CNR2 | P34972 | 2/20 | 0.65 |
| ▸ | PRKCA | P17252 | 2/20 | 0.63 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.59 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.59 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.59 |
| ▸ | FAAH | O00519 | 2/20 | 0.56 |
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | MGLL | Q99685 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3176361 | 1.00 | CNR1 (0.65) | CNR1CNR2PRKCAPRKCEPRKCQ | |
| SCHEMBL8096836 | 0.97 | CNR1 (0.61) | CNR1CNR2PRKCAPRKCEPRKCQ | |
| SCHEMBL31493358 | 0.95 | CNR1 (0.70) | CNR1CNR2PRKCAPRKCEPRKCQ | |
| SCHEMBL31493269 | 0.95 | CNR1 (0.70) | CNR1CNR2PRKCAPRKCEPRKCQ | |
| SCHEMBL31493315 | 0.95 | CNR1 (0.70) | CNR1CNR2PRKCAPRKCEPRKCQ | |
| SCHEMBL3317181 | 0.95 | CNR1 (0.70) | CNR1CNR2PRKCAPRKCEPRKCQ | |
| SCHEMBL5940637 | 0.95 | CNR1 (0.70) | CNR1CNR2PRKCAPRKCEPRKCQ | |
| SCHEMBL2232010 | 0.95 | CNR1 (0.70) | CNR1CNR2PRKCAPRKCEPRKCQ | |
| SCHEMBL31493388 | 0.95 | CNR1 (0.70) | CNR1CNR2PRKCAPRKCEPRKCQ | |
| SCHEMBL3320347 | 0.95 | CNR1 (0.70) | CNR1CNR2PRKCAPRKCEPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9701613-B2 | Preparation method of 1-palmitoyl-3-acetylglycerol, and preparation method of 1-palmitoyl-2-linoleoyl-3-acetylglycerol using same | ENZYCHEM LIFESCIENCES CORPORATION (KR) | 2017-07-11 | — | — | US | disclosed |
| US-20170183287-A1 | PREPARATION METHOD OF 1-PALMITOYL-3-ACETYLGLYCEROL, AND PREPARATION METHOD OF 1-PALMITOYL-2-LINOLEOYL-3-ACETYLGLYCEROL USING SAME | ENZYCHEM LIFESCIENCES CORP (KR) | 2017-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170183287-A1 | PREPARATION METHOD OF 1-PALMITOYL-3-ACETYLGLYCEROL, AND PREPARATION METHOD OF 1-PALMITOYL-2-LINOLEOYL-3-ACETYLGLYCEROL USING SAME | SPTLC1, SPTLC2, LYPLA2 | CNR1 394/4885CNR2 299/4885PRKCA 2368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.